SOUTH SAN FRANCISCO, Calif., Aug. 11, 2011 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today reported financial results for the second quarter ended June 30, 2011. Net loss for the three and six months ended June 30, 2011 was $8.2 million and $6.4 million, respectively. As of June 30, 2011, cash, cash equivalents and marketable securities totaled $48.8 million, with no debt outstanding.
